Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Elekta AB ( ($SE:EKTA.B) ) has shared an update.
Elekta AB has announced a presentation of its second quarter 2025/26 financial results, scheduled for November 26. The event will feature insights from the company’s President and CEO, Jakob Just-Bomholt, and CFO, Tobias Hägglöv, and will include a live webcast and Q&A session. This presentation is significant for stakeholders as it provides an opportunity to gain insights into Elekta’s operational performance and strategic direction.
The most recent analyst rating on ($SE:EKTA.B) stock is a Hold with a SEK43.00 price target. To see the full list of analyst forecasts on Elekta AB stock, see the SE:EKTA.B Stock Forecast page.
More about Elekta AB
Elekta is a leader in precision radiation therapy, dedicated to providing access to top-tier cancer care. The company collaborates with customers to develop sustainable and cost-efficient solutions aimed at improving patient outcomes and enhancing lives. Headquartered in Stockholm, Sweden, Elekta operates in over 40 countries and is listed on Nasdaq Stockholm.
Average Trading Volume: 1,162,036
Technical Sentiment Signal: Sell
Current Market Cap: SEK16.62B
See more data about EKTA.B stock on TipRanks’ Stock Analysis page.